Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Summary Literature (6)
Literature for DOID 219: colon cancer


Xenbase Articles :
( Denotes literature images)
The intestine-specific transcription factor Cdx2 inhibits beta-catenin/TCF transcriptional activity by disrupting the beta-catenin-TCF protein complex., Guo RJ,Funakoshi S,Lee HH,Lee HH,Kong J,Lynch JP, Carcinogenesis. February 1, 2010; 31(2):1460-2180.
Isoquercitrin suppresses colon cancer cell growth in vitro by targeting the Wnt/β-catenin signaling pathway., Amado NG,Predes D,Fonseca BF,Cerqueira DM,Reis AH,Dudenhoeffer AC,Borges HL,Mendes FA,Abreu JG, J Biol Chem. December 19, 2014; 289(51):1083-351X.
Derricin and derricidin inhibit Wnt/β-catenin signaling and suppress colon cancer cell growth in vitro., Fonseca BF,Predes D,Cerqueira DM,Reis AH,Amado NG,Cayres MC,Kuster RM,Oliveira FL,Mendes FA,Abreu JG, PLoS One. March 16, 2015; 10(3):1932-6203.
Modeling endoderm development and disease in Xenopus., Edwards NA,Zorn AM, Curr Top Dev Biol. January 1, 2021; 145:1557-8933.
FGF20., Van Greenen JD,Hockman D, Differentiation. November 7, 2023; 139:1432-0436.
Na,K-ATPase activity promotes macropinocytosis in colon cancer via Wnt signaling., Tejeda-Muñoz N,Azbazdar Y,Sosa EA,Monka J,Wei PS,Binder G,Mei KC,Kurmangaliyev YZ,De Robertis EM, Biol Open. May 15, 2024; 13(5):2046-6390.